Document Detail


Recent progress in antithrombotic therapy for atrial fibrillation.
MedLine Citation:
PMID:  21088368     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Atrial fibrillation (AF) is becoming a major health care burden as elderly populations increase. The increased risk of stroke and thromboembolisms in patients with AF is well documented and anti-coagulation with adjusted-dose warfarin is highly effective in reducing stroke risk, being superior to antiplatelet agents. Despite recognition of the epidemiological problem and the sound evidence base for thromboprophylaxis, as well as major guidelines recommending treatment, anticoagulation use is still suboptimal, given the dis-utility and limitations associated with warfarin. Recent developments in thromboprophylaxis for AF include efforts for better risk stratification for predictions of thromboembolic risk. Constant efforts are underway to develop newer, less cumbersome, alternatives to warfarin with similar (or better) efficacy. This review article provides an overview of the recent progress made, the potential challenges involved and the future of these therapeutic approaches.
Authors:
Selvakumar Velu; Gregory Y H Lip
Related Documents :
21135358 - Geographic and demographic variability in 20-year hypertension incidence: the cardia st...
21496108 - Risk factors for patellar tendinopathy in basketball and volleyball players: a cross-se...
21516458 - Health risk assessment of organochlorine contaminants in fish from a major lake (baiyan...
21233088 - Factors associated with genitourinary medicine clinic attendance and sexually transmitt...
23221728 - Sleep disturbance and incidence of thyroid cancer in postmenopausal women the women's h...
22076008 - Relative survival after transient ischaemic attack: results from the a program of resea...
Publication Detail:
Type:  Journal Article; Review     Date:  2010-11-13
Journal Detail:
Title:  Journal of atherosclerosis and thrombosis     Volume:  18     ISSN:  1880-3873     ISO Abbreviation:  J. Atheroscler. Thromb.     Publication Date:  2011  
Date Detail:
Created Date:  2011-04-27     Completed Date:  2011-10-11     Revised Date:  2011-12-06    
Medline Journal Info:
Nlm Unique ID:  9506298     Medline TA:  J Atheroscler Thromb     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  257-73     Citation Subset:  IM    
Affiliation:
University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Anticoagulants / therapeutic use*
Atrial Fibrillation / drug therapy*
Humans
Risk Assessment / trends
Stroke / etiology,  prevention & control
Thromboembolism / etiology,  prevention & control
Chemical
Reg. No./Substance:
0/Anticoagulants

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Diphenylhydantoin-induced severe yet reversible anemia during pregnancy.
Next Document:  Association and prognostic impact of heart rate and micro- albuminuria in patients with type 2 diabe...